Müller CE - Search Results

1

Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis.

Marcellino D, Carriba P, Filip M, Borgkvist A, Frankowska M, Bellido I, Tanganelli S, Müller CE, Fisone G, Lluis C, Agnati LF, Franco R, Fuxe K. Marcellino D, et al. Among authors: muller ce. Neuropharmacology. 2008 Apr;54(5):815-23. doi: 10.1016/j.neuropharm.2007.12.011. Epub 2008 Jan 9. Neuropharmacology. 2008. PMID: 18262573

2

Electrophysiological and behavioural evidence for an antagonistic modulatory role of adenosine A2A receptors in dopamine D2 receptor regulation in the rat dopamine-denervated striatum.

Strömberg I, Popoli P, Müller CE, Ferré S, Fuxe K. Strömberg I, et al. Among authors: muller ce. Eur J Neurosci. 2000 Nov;12(11):4033-7. doi: 10.1046/j.1460-9568.2000.00288.x. Eur J Neurosci. 2000. PMID: 11069599

3

Metabotropic glutamate mGlu5 receptor-mediated modulation of the ventral striopallidal GABA pathway in rats. Interactions with adenosine A(2A) and dopamine D(2) receptors.

Díaz-Cabiale Z, Vivó M, Del Arco A, O'Connor WT, Harte MK, Müller CE, Martínez E, Popoli P, Fuxe K, Ferré S. Díaz-Cabiale Z, et al. Among authors: muller ce. Neurosci Lett. 2002 May 17;324(2):154-8. doi: 10.1016/s0304-3940(02)00179-9. Neurosci Lett. 2002. PMID: 11988350

4

Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration.

Karcz-Kubicha M, Antoniou K, Terasmaa A, Quarta D, Solinas M, Justinova Z, Pezzola A, Reggio R, Müller CE, Fuxe K, Goldberg SR, Popoli P, Ferré S. Karcz-Kubicha M, et al. Among authors: muller ce. Neuropsychopharmacology. 2003 Jul;28(7):1281-91. doi: 10.1038/sj.npp.1300167. Epub 2003 Apr 9. Neuropsychopharmacology. 2003. PMID: 12700682

5

Involvement of adenosine A2A and dopamine receptors in the locomotor and sensitizing effects of cocaine.

Filip M, Frankowska M, Zaniewska M, Przegaliński E, Muller CE, Agnati L, Franco R, Roberts DC, Fuxe K. Filip M, et al. Among authors: muller ce. Brain Res. 2006 Mar 10;1077(1):67-80. doi: 10.1016/j.brainres.2006.01.038. Epub 2006 Mar 6. Brain Res. 2006. PMID: 16516871

6

Striatal adenosine A2A and cannabinoid CB1 receptors form functional heteromeric complexes that mediate the motor effects of cannabinoids.

Carriba P, Ortiz O, Patkar K, Justinova Z, Stroik J, Themann A, Müller C, Woods AS, Hope BT, Ciruela F, Casadó V, Canela EI, Lluis C, Goldberg SR, Moratalla R, Franco R, Ferré S. Carriba P, et al. Neuropsychopharmacology. 2007 Nov;32(11):2249-59. doi: 10.1038/sj.npp.1301375. Epub 2007 Mar 14. Neuropsychopharmacology. 2007. PMID: 17356572

7

Chronic A2A antagonist treatment alleviates parkinsonian locomotor deficiency in MitoPark mice.

Marcellino D, Lindqvist E, Schneider M, Müller CE, Fuxe K, Olson L, Galter D. Marcellino D, et al. Among authors: muller ce. Neurobiol Dis. 2010 Nov;40(2):460-6. doi: 10.1016/j.nbd.2010.07.008. Epub 2010 Jul 23. Neurobiol Dis. 2010. PMID: 20656029

8

Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist.

Justinová Z, Ferré S, Redhi GH, Mascia P, Stroik J, Quarta D, Yasar S, Müller CE, Franco R, Goldberg SR. Justinová Z, et al. Among authors: muller ce. Addict Biol. 2011 Jul;16(3):405-15. doi: 10.1111/j.1369-1600.2010.00258.x. Epub 2010 Nov 4. Addict Biol. 2011. PMID: 21054689 Free PMC article.

9

Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease.

Armentero MT, Pinna A, Ferré S, Lanciego JL, Müller CE, Franco R. Armentero MT, et al. Among authors: muller ce. Pharmacol Ther. 2011 Dec;132(3):280-99. doi: 10.1016/j.pharmthera.2011.07.004. Epub 2011 Jul 23. Pharmacol Ther. 2011. PMID: 21810444 Free PMC article. Review.

10

Adenosine A2A receptor antagonism and genetic deletion attenuate the effects of dopamine D2 antagonism on effort-based decision making in mice.

Pardo M, Lopez-Cruz L, Valverde O, Ledent C, Baqi Y, Müller CE, Salamone JD, Correa M. Pardo M, et al. Among authors: muller ce. Neuropharmacology. 2012 Apr;62(5-6):2068-77. doi: 10.1016/j.neuropharm.2011.12.033. Epub 2012 Jan 10. Neuropharmacology. 2012. PMID: 22261384

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

571 results

Search Page

Filters